# Celldex Therapeutics, Inc.: Form 8-K, filed Jun 15, 2023

- Company: [Celldex Therapeutics, Inc.](/companies/cldx.md) (CIK 744218)
- Form: 8-K
- Filed: 2023-06-15
- Accepted by EDGAR: Jun 15, 2023, 16:05 ET
- Period: 2023-06-15
- Accession: 0001104659-23-071597
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/744218/000110465923071597/tm2318812d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/744218/000110465923071597/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/744218/000110465923071597/tm2318812d1_8k.htm

Filed Jun 15, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-071597. Last ingested by Listed: Nov 5, 2026, 19:04 ET. No prices; not investment advice.